Delivery Order SPE2DB25D3005-SPE2DB25FQJSF
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $1,544.87 to AmerisourceBergen Drug Corp for the supply of Femring 0.10 mg/day vaginal rings, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,651.13 for the supply of FEMRING 0.05 mg/day vaginal rings under a contract funded by the Defense Logistics Agency's Medical Supply Chain. The award, made on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed price delivery order with no set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,333.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Femring 0.05 mg/day vaginal rings. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $3,635.97 to AmerisourceBergen Drug Corp for the supply of Femring 0.05 mg/day vaginal rings. This is a firm fixed-price, non-set-aside contract awarded on September 18, 2025, with a completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of FEMRING 0.05 MG/DAY vaginal rings, with a potential value of $2,884.82 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- This is a delivery order under contract SPE2DB20D3104 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide FEMRING 0.05 MG/DAY vaginal rings. The $3,865.93 firm-fixed-price order has an ultimate completion date of August 18, 2021. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026, which covers a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Femring 0.05 mg/day vaginal rings, a hormone replacement therapy product. This firm fixed-price delivery order, valued at $1,263.69, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is...
- This is a $1,193.47 fixed-price delivery order awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of FEMRING 0.05 MG/DAY vaginal rings to the U.S. government. The award was made by the Medical Supply Chain, a defense agency under the Defense Logistics Agency (DLA) Troop Support. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $401 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 4562102705 FEMRING 0.05 MG/DAY VAGINAL RINGS. The delivery order is being carried out under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance from September 8-11, 2023. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,558.51, is a delivery order for the supply of FEMRING 0.05 MG/DAY vaginal rings. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQJSFDelivery Order
The Defense Logistics Agency awarded a $1,359.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for FEMRING 0.05 mg/day vaginal rings. This non-set-aside contract was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies the Defense Health System and other military healthcare programs with a comprehensive range of pharmaceutical products and medical supplies. This delivery order represents a continuation of AmerisourceBergen Drug Corp's ongoing support through its substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to deliver medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare operations worldwide. The company's extensive portfolio of federal medical procurement demonstrates its capability to fulfill competitive federal requirements for both routine and specialized pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/15/25 |